NTLA
Intellia Therapeutics, Inc. · Healthcare
EVP and Chief Financial Officer Edward J Dulac III sold $91K of Intellia Therapeutics, Inc.
Sold$91,249
$11.25Price
8,111Shares
−5%Stake
What NTLA did after the filing
- The stock from Mon, Jul 27 open, $10.99
- +11.1%
- S&P 500, same days
- +2.3%
Measured over 30 trading days, to the Sep 9 close.
Traded Wed, Jul 22. Filed Fri, Jul 24, 5:26 PM ET, after the close. Returns use the Jul 27 open and the Sep 9 close. Not investment advice.